PLG and cancer: The potential activity of plasminogen, assessed using the streptokinase method, reached the maximum values in plasma from BC patients with Stages I and II (increased 2.6 and 2.7 fold from thevcontrol values) and increased less prominently in BC patients with stages III (1.6 times) and IV (1.8 times) cancer (Figure 2).